Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease
- PMID: 17018883
- DOI: 10.1177/153537020623100919
Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease
Abstract
We have examined potent peroxynitrite ion (ONOO-) generator 3-morpholinosydnonimine (SIN-1)-induced neurotoxicity in control wild-type (control(wt)) mice, metallothionein double knockout (MT(dko)) mice, metallothionein-transgenic (MT(trans)) mice, and in cultured human dopaminergic (SK-N-SH) neurons to determine the neuroprotective potential of metallothionein against ONOO(-)-induced neurodegeneration in Parkinson disease (PD). SIN-1-induced lipid peroxidation, reactive oxygen species synthesis, caspase-3 activation, and apoptosis were attenuated by metallothionein gene overexpression and augmented by metallothionein gene down-regulation. A progressive nigrostriatal dopaminergic neurodegeneration in weaver mutant (wv/wv) mice was associated with enhanced nitrite ion synthesis, metallothionein down-regulation, and significantly reduced dopamine synthesis and 18F-DOPA uptake as determined by high-resolution micropositron emission tomography neuroimaging. The striatal (18)F-DOPA uptake was significantly higher in MT(trans) mice than in MT(dko) and alpha-synuclein knockout (alpha-Syn(ko)) mice. These observations provide further evidence that nitric oxide synthase activation and ONOO- synthesis may be involved in the etiopathogenesis of PD, and that metallothionein gene induction may provide neuroprotection.
Similar articles
-
Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.Antioxid Redox Signal. 2003 Jun;5(3):251-64. doi: 10.1089/152308603322110832. Antioxid Redox Signal. 2003. PMID: 12880480
-
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011. Brain Res Mol Brain Res. 2005. PMID: 15790531 Free PMC article. Review.
-
Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.Methods Enzymol. 2005;396:276-98. doi: 10.1016/S0076-6879(05)96024-2. Methods Enzymol. 2005. PMID: 16291239
-
Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.J Mol Neurosci. 2006;28(2):125-41. doi: 10.1385/JMN:28:2:125. J Mol Neurosci. 2006. PMID: 16679553
-
Biomarkers in Parkinson's disease (recent update).Neurochem Int. 2013 Sep;63(3):201-29. doi: 10.1016/j.neuint.2013.06.005. Epub 2013 Jun 19. Neurochem Int. 2013. PMID: 23791710 Review.
Cited by
-
Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.PLoS One. 2013 Aug 13;8(8):e72058. doi: 10.1371/journal.pone.0072058. eCollection 2013. PLoS One. 2013. PMID: 23967274 Free PMC article.
-
Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm).Sci Rep. 2016 Mar 1;6:22398. doi: 10.1038/srep22398. Sci Rep. 2016. PMID: 26928495 Free PMC article.
-
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's.Acta Neuropathol Commun. 2022 Sep 8;10(1):134. doi: 10.1186/s40478-022-01424-6. Acta Neuropathol Commun. 2022. PMID: 36076304 Free PMC article.
-
Moringin Pretreatment Inhibits the Expression of Genes Involved in Mitophagy in the Stem Cell of the Human Periodontal Ligament.Molecules. 2019 Sep 4;24(18):3217. doi: 10.3390/molecules24183217. Molecules. 2019. PMID: 31487916 Free PMC article.
-
Up-regulation of metallothionein gene expression in parkinsonian astrocytes.Neurogenetics. 2011 Nov;12(4):295-305. doi: 10.1007/s10048-011-0294-5. Epub 2011 Jul 29. Neurogenetics. 2011. PMID: 21800131
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous